NCT07334314 Olfactive Detection of Urothelial Carcinoma by Sniffer Dogs
| NCT ID | NCT07334314 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Urothelial Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 340 participants |
| Start Date | 2025-06-20 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 340 participants in total. It began in 2025-06-20 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to estimate the sensitivity of olfactory detection of urothelial carcinomas of the bladder in urine samples by assistance dogs trained in this practice.
Eligibility Criteria
Inclusion Criteria: * Adult (\> 18 years old) * Subject scheduled for any endourological surgery involving an initial cystoscopy, the most common of which are: transurethral resection of the bladder, transurethral resection of the prostate, internal optical urethrotomy, bladder lithoclast, ureteral stent replacement, ureteroscopy, etc. (non-exhaustive list) * Subjects for whom a urine sample (for bacteriological or cytological testing) is planned as part of routine practice in the month prior to the procedure * Subjects affiliated with a health insurance plan or beneficiaries of such a plan Exclusion Criteria: * Absence of signed informed consent / inability to provide the subject with informed information (emergency situations, difficulties in understanding the subject, etc.) * Patient under guardianship, conservatorship, or judicial protection * History of cancer other than urothelial bladder carcinoma, unless in complete remission for \> 5 years * Pregnant or breastfeeding women
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07334314 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Urothelial Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07334314 currently recruiting?
Yes, NCT07334314 is actively recruiting participants. Contact the research team at victor.gaillard@chru-strasbourg.fr for enrollment information.
Where is the NCT07334314 trial being conducted?
This trial is being conducted at Colmar, France, Strasbourg, France.
Who is sponsoring the NCT07334314 clinical trial?
NCT07334314 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 340 participants.